Crossref
Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?
AIMS Allergy and Immunology · 2017
DOI: 10.3934/allergy.2017.1.43 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIMS Allergy and Immunology, 2017. Verfasst von Johan Garssen und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Garssen, J., & Jo, J. (2017). Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?. AIMS Allergy and Immunology. https://doi.org/10.3934/allergy.2017.1.43
Vancouver
Garssen J, Jo J. Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?. AIMS Allergy and Immunology. 2017. doi:10.3934/allergy.2017.1.43
BibTeX
@article{Garssen2017,
author = {Garssen, Johan and Jo, Juandy},
title = {Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?},
journal = {AIMS Allergy and Immunology},
year = {2017},
doi = {10.3934/allergy.2017.1.43}
}
EUVIMED